Case number 1:22-cv-00852
Gilead Sciences, Inc. et al v. Natco Pharma Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 22, 2023 | 45 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,599 E; RE44,638 E; 8,865,730 B2; 9,469,643 B2; 10,730,879 B2. (Attachments: # 1 Consent Judgment)(nms) (Entered: 08/22/2023) (0) |
| Aug 22, 2023 | 44 | CONSENT Judgment and Dismissal Order. Signed by Judge Richard G. Andrews on 8/22/2023. Associated Cases: 1:22-cv-00852-RGA, 1:22-cv-01259-RGA(nms) (Entered: 08/22/2023) (3) |
| Aug 21, 2023 | 43 | PROPOSED Consent Judgment and Dismissal Order, by Gilead Sciences, Inc., Gilead Calistoga, LLC. (Tigan, Jeremy) Modified on 8/22/2023 (nms). (Entered: 08/21/2023) (3) |
| Aug 14, 2023 | 42 | ORAL ORDER: The request to continue the stay for an additional 14 days (D.I. 40 ) is GRANTED. Ordered by Judge Richard G. Andrews on 8/14/2023. (lah) (Entered: 08/14/2023) (0) |
| Aug 14, 2023 | 41 | REDACTED VERSION of 40 Status Report by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 08/14/2023) (1) |
| Aug 14, 2023 | 40 | [SEALED] Joint STATUS REPORT by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 08/14/2023) (0) |
| Jun 30, 2023 | 39 | ORAL ORDER: The request to continue the stay for an additional 45 days (D.I. 37 ) is GRANTED. Ordered by Judge Richard G. Andrews on 6/30/2023. (nms) (Entered: 06/30/2023) (0) |
| Jun 30, 2023 | 38 | REDACTED VERSION of 37 Status Report by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 37 | [SEALED] Joint Status Report, by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) Modified on 6/30/2023 (nms). (Entered: 06/30/2023) (0) |
| Jun 2, 2023 | 36 | ORAL ORDER: The request for an additional 30 days to submit a joint status report (D.I. 34 ) is GRANTED. Ordered by Judge Richard G. Andrews on 6/2/2023. (nms) (Entered: 06/02/2023) (0) |
| Jun 2, 2023 | 35 | REDACTED VERSION of 34 Status Report by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 06/02/2023) (1) |
| Jun 2, 2023 | 34 | [SEALED] Joint STATUS REPORT by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 06/02/2023) (0) |
| Apr 12, 2023 | 33 | REDACTED VERSION of 31 Stipulation by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 04/12/2023) (2) |
| Apr 12, 2023 | 32 | [SEALED] ORDER Granting 31 Stipulation and Proposed Order to Stay Proceedings. Signed by Judge Richard G. Andrews on 4/12/2023.This order has been emailed to local counsel. (nms) (Entered: 04/12/2023) (0) |
| Apr 12, 2023 | 31 | [SEALED] STIPULATION and [Proposed] Order to Stay Proceedings by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 04/12/2023) (0) |
| Apr 11, 2023 | 30 | SO ORDERED Granting 29 Stipulation of Dismissal of Eli Lilly and Company and ICOS Corporation. Signed by Judge Richard G. Andrews on 4/11/2023. (nms) (Entered: 04/11/2023) (3) |
| Apr 5, 2023 | 29 | STIPULATION of Dismissal of Eli Lilly and Company and ICOS Corporation - by Eli Lilly and Company, Gilead Calistoga, LLC, Gilead Sciences, Inc., ICOS Corporation. (Tigan, Jeremy) (Entered: 04/05/2023) (3) |
| Feb 23, 2023 | 28 | STIPULATION and Proposed Order to Extend Time for Certain Case Deadlines - filed by Eli Lilly and Company, Gilead Calistoga, LLC, Gilead Sciences, Inc., ICOS Corporation. (Tigan, Jeremy) Modified on 2/23/2023 (nms). (Entered: 02/23/2023) (2) |
| Jan 30, 2023 | 27 | STIPULATION TO EXTEND TIME for (1) Plaintiffs Gilead Sciences, Inc., Gilead Calistoga, LLC, Eli Lilly and Company, and ICOS Corporation to serve their initial infringement contention claim charts; and (2) Defendant Natco Pharma Limited to serve its initial invalidity contentions and accompanying document production to February 28, 2023 and March 30, 2023, respectively - filed by Eli Lilly and Company, Gilead Calistoga, LLC, Gilead Sciences, Inc., ICOS Corporation. (Tigan, Jeremy) (Entered: 01/30/2023) (2) |
| Jan 13, 2023 | 26 | STIPULATION TO EXTEND TIME Defendants to serve Paragraph 3 Disclosures to January 17, 2023 - filed by Natco Pharma Limited. (Green, James) (Entered: 01/13/2023) (1) |
| Jan 12, 2023 | 25 | NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Gilead Sciences, Inc., Eli Lilly and Company, Gilead Calistoga, LLC, ICOS Corporation.(Tigan, Jeremy) (Entered: 01/12/2023) (3) |
| Dec 27, 2022 | 24 | STIPULATION TO EXTEND TIME Time for Parties to Serve Paragraph 3 Disclosures and Infringement and Invalidity Contentions to January 12, 2023, January 31, 2022 and March 2, 2023 - filed by Natco Pharma Limited. (Green, James) (Entered: 12/27/2022) (2) |
| Nov 8, 2022 | 23 | NOTICE OF SERVICE of Defendant's Initial Disclosures Under Fed. R. Civ. P. 26(a)(1) filed by Natco Pharma Limited.(Green, James) (Entered: 11/08/2022) (2) |
| Nov 7, 2022 | 20 | PROPOSED Stipulated Protective Order, by Gilead Sciences, Inc., Eli Lilly and Company, Gilead Calistoga, LLC, ICOS Corporation. (Tigan, Jeremy) Modified on 11/7/2022 (nms). (Entered: 11/07/2022) (22) |
| Nov 7, 2022 | 21 | SO ORDERED Granting (D.I. 20 in 22-cv-852-RGA; D.I. 9 in 22-cv-1259-RGA) Proposed Stipulated Protective Order. Signed by Judge Richard G. Andrews on 11/7/2022. Associated Cases: 1:22-cv-00852-RGA, 1:22-cv-01259-RGA(nms) (Entered: 11/07/2022) (22) |
| Nov 7, 2022 | 22 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Rule 26 Disclosures and (2) Plaintiffs' Disclosures Pursuant to Paragraph 4(a) of the Delaware Default Standard for Discovery filed by Gilead Sciences, Inc., Eli Lilly and Company, Gilead Calistoga, LLC, ICOS Corporation.(Tigan, Jeremy) (Entered: 11/07/2022) (3) |
| Oct 26, 2022 | 19 | STIPULATION and Proposed Order Extending Time to file Protective Order to November 7, 2022 - filed by Natco Pharma Limited. (Green, James) Modified on 10/26/2022 (nms). (Entered: 10/26/2022) (1) |
| Sep 28, 2022 | 18 | MOTION for Pro Hac Vice Appearance of Attorney Charlotte C. Jacobsen, Christine Ranney, Darish Huynh and Kasturi Mitra - filed by Gilead Calistoga, LLC, Gilead Sciences, Inc.. (Tigan, Jeremy) (Entered: 09/28/2022) (7) |
| Sep 27, 2022 | 17 | ORAL ORDER: The Rule 16(b) Conference scheduled for 9/29/2022, is CANCELED. Ordered by Judge Richard G. Andrews on 9/27/2022. (nms) (Entered: 09/27/2022) (0) |
| Sep 27, 2022 | 16 | SCHEDULING ORDER: Joinder of Parties due by 7/28/2023. Amended Pleadings due by 7/28/2023. Discovery due by 11/13/2023. Joint Claim Construction Brief due by 7/28/2023. A Markman Hearing is set for 8/29/2023, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 8/16/2024, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set to start 8/26/2024, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 9/27/2022. (nms) (Entered: 09/27/2022) (10) |
| Sep 27, 2022 | 15 | PROPOSED Scheduling Order, by Eli Lilly and Company, Gilead Calistoga, LLC, Gilead Sciences, Inc., ICOS Corporation. (Tigan, Jeremy) Modified on 9/27/2022 (nms). (Entered: 09/27/2022) (12) |
| Sep 8, 2022 | 14 | Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 9/29/2022, at 3:00 PM (see Order for further details). Signed by Judge Richard G. Andrews on 9/8/2022. (nms) (Entered: 09/08/2022) (1) |
| Sep 6, 2022 | 13 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Natco Pharma Limited. (Green, James) (Entered: 09/06/2022) (2) |
| Sep 6, 2022 | 12 | ANSWER to 1 Complaint, and Affirmative Defenses, by Natco Pharma Limited.(Green, James) Modified on 9/6/2022 (nms). (Entered: 09/06/2022) (30) |
| Aug 30, 2022 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Christopher Sorenson - filed by Natco Pharma Limited. (Green, James) (Entered: 08/30/2022) (2) |
| Aug 30, 2022 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Hayley Ostrin - filed by Natco Pharma Limited. (Green, James) (Entered: 08/30/2022) (2) |
| Aug 30, 2022 | 9 | MOTION for Pro Hac Vice Appearance of Attorney Andrew Larsen - filed by Natco Pharma Limited. (Green, James) (Entered: 08/30/2022) (2) |
| Aug 29, 2022 | 8 | STIPULATION and Proposed Order for Extension of Time to Respond to Complaint - filed by Natco Pharma Limited. (Green, James) Modified on 8/29/2022 (nms). (Entered: 08/29/2022) (1) |
| Jul 12, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Gilead Sciences, Inc., Gilead Calistoga, LLC, Eli Lilly and Company, ICOS Corporation: For Natco Pharma Limited waiver sent on 6/29/2022, answer due 8/29/2022. (Tigan, Jeremy) |
| Jun 29, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jun 23, 2022 | 1 | Complaint* (1) |
| Jun 23, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to Natco Pharma Limited on 6/24/2022. (twk) |
| Jun 23, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Eli Lilly and Company for ICOS Corporation; Corporate Parent Gilead Sciences, Inc. for Gilead Calistoga, LLC filed by Eli Lilly and Company, Gilead Calistoga, LLC, Gilead Sciences, Inc., ICOS Corporation. (twk) |
| Jun 23, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,599 E; RE44,638 E; 8,865,730 B2; 9,469,643 B2; 10,730,879 B2. (twk) |
| Jun 23, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 11, 2022. Date of Expiration of RE44,599 Patent: July 21, 2025. Date of Expiration of RE44,638 Patent: August 5, 2025. Date of Expiration of 8,865,730 Patent: March 5, 2033. Date of Expiration of 9,469,643 Patent: September 2, 2033. Date of Expiration of 10,730,879 Patent: March 5, 2033. Thirty Month Stay Deadline: 11/11/2024. (twk) |
| Jun 23, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Jun 23, 2022 | 1 | Civil Cover Sheet (2) |
| Jun 23, 2022 | 1 | Exhibit A-E (305) |
| Jun 23, 2022 | 1 | Main Document (32) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Natco Pharma Limited ( Filing fee $ 402, receipt number ADEDC-3902222.) - filed by Gilead Sciences, Inc., Gilead Calistoga, LLC, Eli Lilly and Company, ICOS Corporation. (Attachments: # (1) Exhibit A-E, # (2) Civil Cover Sheet)(twk) |
